Northern Trust’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EP
VCM
YCM
IC
EAM
Northern Trust's PASG Position: Q1 2026 in Review
Northern Trust sold out of Passage Bio (PASG) in Q1 2026, closing a stake of 14,217 shares — an estimated $168K sold.
Northern Trust first reported a position in PASG in Q2 2020 and held it in 22 quarters. The position peaked at $6.78M in Q4 2020. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.
- Northern Trust reported no remaining Passage Bio position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 14,217 Passage Bio shares in Q1 2026, an estimated $168K.
- Northern Trust first reported a position in Passage Bio in Q2 2020 and held it in 22 quarters.
- Northern Trust's Passage Bio position peaked at $6.78M in Q4 2020.
- 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.